Monte Rosa Therapeutics (GLUE) Current Assets (2023 - 2025)
Historic Current Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $401.8 million.
- Monte Rosa Therapeutics' Current Assets rose 5995.45% to $401.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $401.8 million, marking a year-over-year increase of 5995.45%. This contributed to the annual value of $377.4 million for FY2024, which is 5978.87% up from last year.
- Monte Rosa Therapeutics' Current Assets amounted to $401.8 million in Q3 2025, which was up 5995.45% from $299.5 million recorded in Q2 2025.
- Monte Rosa Therapeutics' Current Assets' 5-year high stood at $401.8 million during Q3 2025, with a 5-year trough of $182.9 million in Q3 2023.
- Its 3-year average for Current Assets is $273.4 million, with a median of $251.2 million in 2024.
- Per our database at Business Quant, Monte Rosa Therapeutics' Current Assets crashed by 1726.0% in 2024 and then soared by 6694.47% in 2025.
- Over the past 3 years, Monte Rosa Therapeutics' Current Assets (Quarter) stood at $236.2 million in 2023, then skyrocketed by 59.79% to $377.4 million in 2024, then grew by 6.46% to $401.8 million in 2025.
- Its Current Assets stands at $401.8 million for Q3 2025, versus $299.5 million for Q2 2025 and $332.3 million for Q1 2025.